Targeting arginine methyltransferase PRMT5 for cancer therapy: updated progress and novel strategies
J Zheng, B Li, Y Wu, X Wu, Y Wang - Journal of Medicinal …, 2023 - ACS Publications
As a predominant type II protein arginine methyltransferase, PRMT5 plays critical roles in
various normal cellular processes by catalyzing the mono-and symmetrical dimethylation of …
various normal cellular processes by catalyzing the mono-and symmetrical dimethylation of …
Versatility of PRMT5-induced methylation in growth control and development
V Karkhanis, YJ Hu, RA Baiocchi, AN Imbalzano… - Trends in biochemical …, 2011 - cell.com
Arginine methylation governs important cellular processes that impact growth and
proliferation, as well as differentiation and development. Through their ability to catalyze …
proliferation, as well as differentiation and development. Through their ability to catalyze …
LLY-283, a potent and selective inhibitor of arginine methyltransferase 5, PRMT5, with antitumor activity
ZQ Bonday, GS Cortez, MJ Grogan… - ACS medicinal …, 2018 - ACS Publications
Protein arginine methyltransferase 5 (PRMT5) is a type II arginine methyltransferase that
catalyzes the formation of symmetric dimethylarginine in a number of nuclear and …
catalyzes the formation of symmetric dimethylarginine in a number of nuclear and …
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
AKT is involved in a number of key cellular processes including cell proliferation, apoptosis
and metabolism. Hyperactivation of AKT is associated with many pathological conditions …
and metabolism. Hyperactivation of AKT is associated with many pathological conditions …
ATR is essential for preservation of cell mechanics and nuclear integrity during interstitial migration
GR Kidiyoor, Q Li, G Bastianello, C Bruhn… - Nature …, 2020 - nature.com
ATR responds to mechanical stress at the nuclear envelope and mediates envelope-
associated repair of aberrant topological DNA states. By combining microscopy, electron …
associated repair of aberrant topological DNA states. By combining microscopy, electron …
[HTML][HTML] Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
Protein arginine methyltransferases (PRMTs) are known for their ability to catalyze
methylation of specific arginine residues in a wide variety of cellular proteins, which are …
methylation of specific arginine residues in a wide variety of cellular proteins, which are …
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
Y Jin, J Zhou, F Xu, B Jin, L Cui, Y Wang… - The Journal of …, 2016 - Am Soc Clin Investig
Imatinib-insensitive leukemia stem cells (LSCs) are believed to be responsible for resistance
to BCR-ABL tyrosine kinase inhibitors and relapse of chronic myelogenous leukemia (CML) …
to BCR-ABL tyrosine kinase inhibitors and relapse of chronic myelogenous leukemia (CML) …
Golgi structure and function in health, stress, and diseases
The Golgi apparatus is a central intracellular membrane-bound organelle with key functions
in trafficking, processing, and sorting of newly synthesized membrane and secretory proteins …
in trafficking, processing, and sorting of newly synthesized membrane and secretory proteins …
MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1–Cdc25 pathway
R Gruber, Z Zhou, M Sukchev, T Joerss… - Nature cell …, 2011 - nature.com
Primary microcephaly 1 is a neurodevelopmental disorder caused by mutations in the
MCPH1 gene, whose product MCPH1 (also known as microcephalin and BRIT1) regulates …
MCPH1 gene, whose product MCPH1 (also known as microcephalin and BRIT1) regulates …
Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT …
Increasing evidence suggests that PRMT 5, a protein arginine methyltransferase, is involved
in tumorigenesis. However, no systematic research has demonstrated the cell‐transforming …
in tumorigenesis. However, no systematic research has demonstrated the cell‐transforming …